Join or Renew Your Membership Join

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Ethics

Thursday 04/15/10
02:45 PM - 03:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Ethics, Pain and Palliative Care
No CME available
Event Timeline
02:45 PM - 03:45 PM Abstract 001 - Significant Pain Relief in Treatment Resistant Neuropathic Pain. Results from the First Multicenter, Randomized Trial with Intravenous Immunoglobulin (IGD 001 Trial, Eudract 2007-007007-32)
02:45 PM - 03:45 PM Abstract 002 - Evaluation of Neurogenic Intermittent Claudication in Lumbar Spinal Stenosis
02:45 PM - 03:45 PM Abstract 003 - Functional Connectivity in Patients with Chronic Neuropathic Pain
02:45 PM - 03:45 PM Abstract 004 - Functional Polymorphisms of Catechol-O-Methyl Transferase (COMT) and Dopamine Beta-Hydroxylase (DBH) and Chronic Pain in the Elderly
Faculty Disclosures
Michael M. Dowling, MD, PhD, FAAN Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.
Jill Conway, MD No disclosure on file
John Markman, MD, FAAN Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio Biosciences. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem Therapeutics. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Trevena. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grunenthal. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lateral Pharma. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avenue Therapeutics. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Markman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Markman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Markman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix Pharmaceuticals. Dr. Markman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Flowonix. Dr. Markman has stock in Yellowblack Corporation.
Stefano Jann, MD No disclosure on file
Maria Fruguglietti, MD No disclosure on file
No disclosure on file
Meredith J. Barad, MD Dr. Barad has nothing to disclose.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Laurie J. Ozelius, PhD The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Lucas McCarthy, MD Dr. McCarthy has received personal compensation for serving as an employee of Virginia Mason Medical Center.
Elena Call, MD Dr. Call has nothing to disclose.
Ada Francia, MD No disclosure on file
Sean Mackey, MD, PhD No disclosure on file
Arleen Brown No disclosure on file
Arturo Violante-Villanueva, MD No disclosure on file